-
Je něco špatně v tomto záznamu ?
Importance of vancomycin loading doses in intermittent infusion regimens
M. Šíma, J. Hartinger, T. Cikánková, O. Slanař,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, pozorovací studie
- MeSH
- antibakteriální látky aplikace a dávkování krev farmakokinetika farmakologie MeSH
- infuzní pumpy MeSH
- kreatinin krev MeSH
- lidé MeSH
- monitorování léčiv metody MeSH
- plocha pod křivkou MeSH
- počítačová simulace MeSH
- retrospektivní studie MeSH
- senioři MeSH
- vankomycin aplikace a dávkování krev farmakokinetika farmakologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
PURPOSE: Delayed achievement of target vancomycin serum concentrations may adversely affect clinical outcomes. The objective of this retrospective study was to explore the real frequency of loading dose use and to evaluate the impact of loading dose for the achievement of vancomycin PK/PD target in adult patients treated with intermittent vancomycin. As a secondary aim we determined optimal vancomycin loading dose based on individual pharmacokinetic calculations. METHODS: Vancomycin pharmacokinetic models were computed using two-compartmental analysis. Based on these models AUC24 were calculated. Unpaired t-test was used to compare AUC24 achieved in patients treated with and without vancomycin loading dose. RESULTS: Vancomycin loading dose was administered only in 17.8% patients. Volume of distribution and clearance median values (interquartile range) for vancomycin in whole study population (n = 45) were 0.69 (0.55-0.87) L/kg and 0.0304 (0.0217-0.0501) L/h/kg, respectively. The AUC24 was significantly higher in patients taking loading dose compared with the group without loading dose: mean (SD) AUC24 was 496 (101) vs. 341 (77) mg h/L. Proportion of patients reaching PK/PD goal was 87.5% and 24.3% with and without loading dose administration, respectively. Considering individual pharmacokinetic parameters optimal vancomycin loading dose was 27.5 mg/kg of body weight. CONCLUSIONS: Loading dose administration plays crucial part in rapid attainment of vancomycin PK/PD target in adult patient treated with intermittent vancomycin, although it is not frequently used in clinical practise. The optimal loading dose of 25-30 mg/kg of body weight should be routinely administered to adult patients treated with intermittent vancomycin.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033500
- 003
- CZ-PrNML
- 005
- 20240522100346.0
- 007
- ta
- 008
- 181008s2018 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jiac.2017.11.002 $2 doi
- 035 __
- $a (PubMed)29195829
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Šíma, Martin $u Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Albertov 4, 128 00 Prague 2, Czech Republic. Electronic address: martin.sima@lf1.cuni.cz.
- 245 10
- $a Importance of vancomycin loading doses in intermittent infusion regimens / $c M. Šíma, J. Hartinger, T. Cikánková, O. Slanař,
- 520 9_
- $a PURPOSE: Delayed achievement of target vancomycin serum concentrations may adversely affect clinical outcomes. The objective of this retrospective study was to explore the real frequency of loading dose use and to evaluate the impact of loading dose for the achievement of vancomycin PK/PD target in adult patients treated with intermittent vancomycin. As a secondary aim we determined optimal vancomycin loading dose based on individual pharmacokinetic calculations. METHODS: Vancomycin pharmacokinetic models were computed using two-compartmental analysis. Based on these models AUC24 were calculated. Unpaired t-test was used to compare AUC24 achieved in patients treated with and without vancomycin loading dose. RESULTS: Vancomycin loading dose was administered only in 17.8% patients. Volume of distribution and clearance median values (interquartile range) for vancomycin in whole study population (n = 45) were 0.69 (0.55-0.87) L/kg and 0.0304 (0.0217-0.0501) L/h/kg, respectively. The AUC24 was significantly higher in patients taking loading dose compared with the group without loading dose: mean (SD) AUC24 was 496 (101) vs. 341 (77) mg h/L. Proportion of patients reaching PK/PD goal was 87.5% and 24.3% with and without loading dose administration, respectively. Considering individual pharmacokinetic parameters optimal vancomycin loading dose was 27.5 mg/kg of body weight. CONCLUSIONS: Loading dose administration plays crucial part in rapid attainment of vancomycin PK/PD target in adult patient treated with intermittent vancomycin, although it is not frequently used in clinical practise. The optimal loading dose of 25-30 mg/kg of body weight should be routinely administered to adult patients treated with intermittent vancomycin.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antibakteriální látky $x aplikace a dávkování $x krev $x farmakokinetika $x farmakologie $7 D000900
- 650 _2
- $a plocha pod křivkou $7 D019540
- 650 _2
- $a počítačová simulace $7 D003198
- 650 _2
- $a kreatinin $x krev $7 D003404
- 650 _2
- $a monitorování léčiv $x metody $7 D016903
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a infuzní pumpy $7 D007260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a vankomycin $x aplikace a dávkování $x krev $x farmakokinetika $x farmakologie $7 D014640
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Hartinger, Jan $u Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Albertov 4, 128 00 Prague 2, Czech Republic. Electronic address: jan.hartinger@vfn.cz. $7 xx0224709
- 700 1_
- $a Cikánková, Tereza, $u Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Albertov 4, 128 00 Prague 2, Czech Republic. Electronic address: terez.dan@seznam.cz. $d 1986- $7 xx0268197
- 700 1_
- $a Slanař, Ondřej $u Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Albertov 4, 128 00 Prague 2, Czech Republic. Electronic address: ondrej.slanar@lf1.cuni.cz.
- 773 0_
- $w MED00005760 $t Journal of infection and chemotherapy $x 1437-7780 $g Roč. 24, č. 4 (2018), s. 247-250
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29195829 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20240522100342 $b ABA008
- 999 __
- $a ok $b bmc $g 1339479 $s 1030494
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 24 $c 4 $d 247-250 $e 20171128 $i 1437-7780 $m Journal of infection and chemotherapy $n J Infect Chemother $x MED00005760
- LZP __
- $a Pubmed-20181008